Rhonda Patrick· PhD
The other one that's coming out is the AstraZeneca, Oxford one. Does the very same thing, except instead of using mRNA in a little, like, a lipid droplet, like a butter droplet, if you like, it's using a different vector, it's actually using a chimpanzee adenovirus that you're like, why would you use a chimpanzee adenovirus? Well, it's because humans haven't seen chimpanzee adenovirus. And so we don't want to have a vector used in that situation that could be recognized by the immune system and destroy the vector before the message gets into the cell. In this case, the message is not an mRNA, it's actually a DNA. And so the DNA goes into the nucleus in the AstraZeneca, Oxford version, where it is transcribed into an mRNA.